Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vaccinia virus (VV) inhibits the presentation of certain epitopes from influenza virus nucleoprotein (NP), haemagglutinin (HA) and non-structural 1 (NS1) proteins to CD8+ cytotoxic T lymphocytes (CTL) by an unknown mechanism. We have investigated whether VV genes B13R and B22R, which encode proteins with amino acid similarity to serine protease inhibitors (serpins), are involved in this process. Recombinant VVs were constructed which express influenza virus proteins HA, NP or NS1 and which lack serpin gene B13R or both B13R and B22R. The lysis of cells infected with these viruses by influenza virus-specific CD8+ CTL was compared to the lysis of cells infected with viruses expressing both the influenza proteins and the serpin genes. Cytotoxicity assays showed that deletion of the VV serpin genes B13R and B22R and other genes between B13R and B24R did not increase the level of lysis, indicating that these genes are not involved in inhibition of antigen presentation of the epitopes tested.

Original publication




Journal article


J Gen Virol

Publication Date



76 ( Pt 9)


2393 - 2398


Animals, Antigen Presentation, Cell Line, Hemagglutinin Glycoproteins, Influenza Virus, Hemagglutinins, Viral, Histocompatibility Antigens Class I, Influenza A virus, Mice, Nucleoproteins, RNA-Binding Proteins, Recombinant Fusion Proteins, Serpins, T-Lymphocytes, Cytotoxic, Vaccinia virus, Viral Core Proteins, Viral Nonstructural Proteins, Viral Proteins